HIV InfectionsHIV SeropositivityHIV SeroprevalenceHIV SeronegativityHIV-1Anti-HIV AgentsAIDS SerodiagnosisHIV AntigensAcquired Immunodeficiency SyndromeSexual BehaviorHIV Protease InhibitorsHomosexuality, MaleViral LoadCD4 Lymphocyte CountTime FactorsRisk-TakingAnti-Retroviral AgentsHIV Core Protein p24LactaseHIV Reverse TranscriptasePrevalenceSouth AfricaHIV Envelope Protein gp120Sexual PartnersReceptors, HIVHIV ProteaseSubstance Abuse, IntravenousVirus ReplicationRNA, ViralCD4-Positive T-LymphocytesRisk FactorsUgandaAIDS-Related Opportunistic InfectionsHIV Long-Term SurvivorsCondomsVirus LatencyCoinfectionCohort StudiesUnsafe SexCross-Sectional StudiesDNA, ViralHealth Knowledge, Attitudes, PracticeZimbabweMolecular Sequence DataMedication AdherenceCounselingUnited StatesFetal HemoglobinHIV EnteropathyPolymerase Chain ReactionEpidemicsProstitutionPregnancyHepatitis CVoluntary ProgramsCD8-Positive T-LymphocytesHIV Envelope Protein gp41HemoglobinopathiesCell LineSafe SexPatient ComplianceAfrica South of the SaharaMalawiAIDS Dementia ComplexHeterosexualityProspective StudiesIncidenceFollow-Up StudiesMutationPopulation DynamicsViremiaZambiaDrug Resistance, ViralLongitudinal StudiesTuberculosisCells, CulturedQuestionnairesMass ScreeningCircumcision, MaleIndiaHost-Pathogen InteractionsModels, BiologicalBase SequenceHIV Fusion InhibitorsHIV Wasting SyndromeTreatment OutcomeSyphilisPapillomavirus InfectionsHIV Integrase InhibitorsSocial StigmaStereotypingPatient Acceptance of Health CareMicrobial ViabilityHomosexualityRetrospective StudiesVirulenceT-LymphocytesChronic DiseaseSocioeconomic FactorsSubstance-Related Disorders